BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MedCath Corporation (MDTH) Stockholders Approve Proposals to Sell All Remaining Assets


9/23/2011 6:08:15 AM

CHARLOTTE, N.C., Sept. 22, 2011 /PRNewswire/ -- MedCath Corporation (Nasdaq: MDTH) announced that the company's stockholders today approved the proposals contained in a proxy statement filed with the Securities and Exchange Commission on August 17, 2011, authorizing the sale of substantially all of the remaining assets of MedCath and the dissolution of the company.

MedCath also announced today that its Board of Directors approved a cash distribution equal to $6.85 per share, which will be paid October 13, 2011 to stockholders of record on October 6, 2011. The amount of the distribution is consistent with the amount of the anticipated initial distribution described in the proxy statement dated August 17, 2011.

MedCath announced in March 2010 it had formed a Strategic Options Committee to consider the sale either of the entire company or its assets. Since that time, the company has announced 10 transactions.

About MedCath

MedCath Corporation, headquartered in Charlotte, N.C., is a health care provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates four hospitals with a total of 366 licensed beds, located in Arizona, California, Louisiana and Texas. This press release contains a forward-looking statement relating to the payment of a cash distribution to stockholders. The payment of this distribution is subject to various risks, including those described in MedCath's Annual Report on Form 10-K, as amended, and its subsequent filings with the Securities and Exchange Commission. Actual results could differ materially from those projected in this forward-looking statement. MedCath assumes no obligation to update statements contained in this press release.

SOURCE MedCath Corporation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES